Judith Sailer

Ms. Judith Sailer

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AFAdriana Fontes
Adriana Fontes
AJAdrian T. Jauch
Adrian T. Jauch
JSJudith Sailer
Judith Sailer
JEJonas Engler
Jonas Engler
AAAnabela Marisa Azul
Anabela Marisa Azul
HZHans Zischka
Hans Zischka
Essential transition metals have key roles in oxygen transport, neurotransmitter synthesis, nucleic acid repair, cellular structure maintenance and stability, oxidative phosphorylation, and metabolism. The balance between metal deficiency and excess is typically ensured by several extracellular and intracellular mechanisms involved in uptake, distribution, and excretion. However, provoked by either intrinsic or extrinsic factors, excess iron, zinc, copper, or manganese can lead to cellular damage upon chronic or acute exposure, frequently attributed to oxidative stress. Intracellularly, mitochondria are the organelles that require the tightest control concerning reactive oxygen species production, which inevitably leaves them to be one of the most vulnerable targets of metal toxicity. Current therapies to counteract metal overload are focused on chelators, which often cause secondary effects decreasing patients’ quality of life. New therapeutic options based on synthetic or natural antioxidants have proven positive effects against metal intoxication. In this review, we briefly address the cellular metabolism of transition metals, consequences of their overload, and current therapies, followed by their potential role in inducing oxidative stress and remedies thereof.

Verified
Journal Article
Open access
PDF file
JSJudith Sailer
Judith Sailer
SSSabine Schmitt
Sabine Schmitt
HZHans Zischka
Hans Zischka
EGErich Gnaiger
Erich Gnaiger
Antibiotics are indispensable in medical patient care, yet they may elicit off-target effects, particularly by affecting mitochondrial function. This study investigates three commonly used antibiotics, gentamicin, ciprofloxacin, and amoxicillin, for their direct effects on mitochondrial respiration and membrane potential. Using high-resolution respirometry, we show that gentamicin and ciprofloxacin markedly increase mitochondrial leak respiration in permeabilized human embryonic kidney cells, suggesting alterations in the mitochondrial inner membrane. This is supported by a gentamicin-induced decrease in mitochondrial membrane potential. Especially gentamicin, but also ciprofloxacin, dose- and time-dependently inhibit oxidative phosphorylation and the mitochondrial electron transfer capacity, pronouncedly in the NADH-linked but also in the succinate-linked pathway. Furthermore, gentamicin decreases Complex IV (CIV) activity in a time-dependent fashion. In contrast, amoxicillin has no significant effect on mitochondrial respiration. These findings emphasize the importance of evaluating the potential direct toxicity of antibiotics on mitochondria, as they are most critical off-target sites. High-resolution respirometry provides a powerful approach to characterize such effects early in the drug development process.

6 January 2026 in JCI Insight
Verified
Journal Article
Open access
PDF file
WGWen Gu
Wen Gu
NWNicole Wilkinson
Nicole Wilkinson
CFCarine Fillebeen
Carine Fillebeen
DBDarren M. Blackburn
Darren M. Blackburn
KSKorin Sahinyan
Korin Sahinyan
Kostas PantopoulosKostas Pantopoulos
Kostas Pantopoulos
Iron regulatory protein 1 (IRP1) is a posttranscriptional regulator of cellular iron metabolism. In mice, loss of IRP1 causes polycythemia through translational de-repression of HIF2α mRNA, which increases renal erythropoietin production. Here, we show that Irp1 –/– mice develop fasting hypoglycemia and are protected against high-fat diet–induced hyperglycemia and hepatic steatosis. Discovery-based proteomics of Irp1 –/– livers revealed a mitochondrial dysfunction signature. Seahorse flux analysis in primary hepatocytes and differentiated skeletal muscle myotubes confirmed impaired respiratory capacity, with a shift from oxidative phosphorylation to glycolytic ATP production. This metabolic rewiring was associated with enhanced insulin sensitivity and increased glucose uptake in skeletal muscle. Under metabolic stress, IRP1 deficiency altered the redox balance of mitochondrial iron, resulting in inefficient energy production and accumulation of amino acids and metabolites in skeletal muscles, rendering them unavailable for hepatic gluconeogenesis. These findings identify IRP1 as a critical regulator of systemic energy homeostasis.

4 December 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JEJonas Engler
Jonas Engler
EKEun-Jung Kim
Eun-Jung Kim
DKDasol Kim
Dasol Kim
NSNoreene M. Shibata
Noreene M. Shibata
ELEmilie Munk Lynderup
Emilie Munk Lynderup
HZHans Zischka
Hans Zischka
In Wilson disease (WD), excess copper provokes hepatocyte death due to impaired copper excretion, ultimately causing either acute or chronic liver damage. Current therapeutic compounds fail to reduce hepatic copper near to physiological levels, leaving lifelong, several times daily treatment as the only choice for patients. We have previously shown that a bacteria-derived methanobactin, termed ARBM-101, most efficiently depleted excess liver copper in still healthy WD rats. Here we report, for the first time, that mechanistically this is due to endosomal/lysosomal/exosomal trafficking of ARBM-101 in WD hepatocytes, allowing for copper mass excretion via the biliary/fecal route. We further show that such liver copper excretion occurs within minutes in vivo to detect copper-bound ARBM-101 in feces. This efficacy allows for specialized treatment regimen to rescue acute liver failure in WD rats. Moreover, also shown for the first time, it avoids fibrosis development in WD mice. Thus, judging from the results in two rodent species and human hepatocytes, this study advocates the development of ARBM-101 for WD therapy.

19 September 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JSJudith Sailer
Judith Sailer
JGJonas Gottal
Jonas Gottal
.K.Leon Kaub
.Leon Kaub
AJAdrian T. Jauch
Adrian T. Jauch
JEJonas Engler
Jonas Engler
HZHans Zischka
Hans Zischka
A long-standing clinical conundrum is the pronounced phenotypic heterogeneity of hereditary hemochromatosis. Patients with identical HFE genotypes and similar degrees of iron overload can have vastly different clinical outcomes, ranging from being completely asymptomatic to developing severe cirrhosis, diabetes, or cardiomyopathy. This variability strongly implies the existence of genetic or environmental modifiers that dictate disease penetrance. Here, copper may be a compelling disease-modifying candidate, due to its intimately intertwined metabolism with iron. Indeed, profound iron loading in hemochromatosis mice ( Hfe knockout) and hemochromatosis Huh7 hepatocytes does not cause overt toxicity. However, the addition of copper, even in trace amounts and harmless on its own, dramatically amplifies adverse effects to induce profound cell toxicity. We find that copper-provoked iron vulnerability is not driven by Fenton chemistry-driven ROS damage, but instead induces a cuproptotic-like mechanism, characterized by proteotoxic stress, loss of iron-sulfur cluster enzyme activity, and severe mitochondrial dysfunction. Remarkably, high-affinity copper chelation rescued Huh7 cells, whereas inhibition of other canonical cell death pathways did not. These findings spotlight copper as a critical modifier in iron overload toxicity, capable of converting largely compensated iron overload into severe cellular injury and death, thereby providing a mechanistic explanation for the phenotypic heterogeneity in hemochromatosis.

24 November 2025 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Open access
EFEvelyn Fast
Evelyn Fast
JJJana Jakobs
Jana Jakobs
JBJens Bertram
Jens Bertram
IWInga Wessels
Inga Wessels
JSJudith Sailer
Judith Sailer
Lothar RinkLothar Rink
Lothar Rink
Iron overload is a common phenomenon in patients undergoing transfusions or organ transplantation. Clinical studies indicate that iron overload interferes with immune function. Baseless supplementation of iron leads to higher morbidity and mortality. In iron overload T-cell differentiation is skewed towards a Th2 response, with lower levels of interferon (IFN)-γ. Zinc is known for its immune balancing abilities, e.g., by induction of regulatory T cells. This study aims to investigate the interaction of iron and zinc in mixed lymphocyte cultures (MLC). MLC, peripheral blood mononuclear cells (PBMC) stimulation with phytohemagglutinin, ELISA, PCR, and ICP-MS were used as methods. Zn2+ supplementation leads to a significantly lower IFN-γ production in MLC compared with control (P<.03). Fe2+ supplementation lowers the IFN-γ production in MLC (P<.0017), too. However, Fe3+ has a slightly increasing effect on IFN-γ release which differs significantly from Fe2+ (P<.03). In 2,2-Bipyridyl-induced iron deficiency IFN-γ production is lowered (P<.0003), whereas zinc deficiency does not significantly affect IFN-γ production. Examinations of Interleukin (IL)-2 and IL-6 show comparable tendencies. The Fe2+ effect can be imitated by sodium sulfite. Fe3+ treatment increases intracellular free iron in peripheral blood mononuclear cells (PBMC) significantly compared to Fe2+ treatment (P<.02). Iron (II) and zinc both suppress cytokine production in MLC. Fe3+ shows a significantly different effect on IFN-γ production. The underlying mechanism is likely a donation of electrons by Fe2+ or oxidative stress. These findings provide mechanistic insights on how the oxidation state of iron differentially modulates human immune cell function and highlights the importance of iron speciation in nutritional immunology.